The Hippo pathway effectors YAP and TAZ promote cell growth by modulating amino acid signaling to mTORC1

Hansen, Carsten Gram, Ng, Yuen Lam Dora, Lam, Wai-Ling Macrina, Plouffe, Steven W, Guan, Kun-Liang·2015·Cell Research
DOI 10.1038/cr.2015.140

Cited by (212)

Items 101–200 of 212

  1. Integrin‐FAK‐CDC42‐PP1A signaling gnaws at YAP/TAZ activity to control incisor stem cells
    Julia Hicks‐Berthet, Xaralabos Varelas · 2017 · BioEssays
  2. Insights into Metabolic Reprogramming in Tumor Evolution and Therapy
    Ching‐Feng Chiu, Jonathan Jaime G. Guerrero, Ric Ryan H. Regalado, Jiayan Zhou, Kin Israel Notarte, Yuwei Lu, Paolo C. Encarnacion, Cidne Carles, Edrian M. Octavo, Dan Christopher I. Limbaroc et al. · 2024 · Cancers
  3. The Hippo signaling effector WWTR1 is a metastatic biomarker of gastric cardia adenocarcinoma
    Jing Wei, Lincui Wang, Jun Zhu, Aiqin Sun, Guanzhen Yu, Miao Chen, Pan Huang, Hanqing Liu, Genbao Shao, Wannian Yang et al. · 2019 · Cancer Cell International
  4. Hippo pathway effectors YAP and TAZ and their association with skeletal muscle ageing
    Iwan Setiawan, Ardo Sanjaya, Ronny Lesmana, Paul M. Yen, Hanna Goenawan · 2021 · Journal of Physiology and Biochemistry
  5. Amino acid metabolism regulated by lncRNAs: the propellant behind cancer metabolic reprogramming
    Qifan Hu, Yutong Li, Dan Li, Yi Yuan, Keru Wang, Yao Lü, Zhujun Cheng, Tianyu Han · 2023 · Cell Communication and Signaling
  6. Bisphenol A induces placental ferroptosis and fetal growth restriction via the YAP/TAZ-ferritinophagy axis
    Yanan Sun, Menghan Sha, Qin Yu, Juan Xiao, Wei Li, Shufang Li, Suhua Chen · 2024 · Free Radical Biology and Medicine
  7. The cross-talk between the Hippo signaling pathway and autophagy:implications on physiology and cancer
    Fengyuan Tang, Gerhard Christofori · 2020 · Cell Cycle
  8. New Insights into YES-Associated Protein Signaling Pathways in Hematological Malignancies: Diagnostic and Therapeutic Challenges
    Alessandro Allegra, Giovanni Pioggia, Vanessa Innao, Caterina Musolino, Sebastiano Gangemi · 2021 · Cancers
  9. Disruption of adipocyte YAP improves glucose homeostasis in mice and decreases adipose tissue fibrosis
    Daniel J. Han, Rukhsana Aslam, Paraish S. Misra, Felix Chiu, Tanvi Ojha, Apu Chowdhury, Carmen K. Chan, Hoon‐Ki Sung, Darren A. Yuen, Cynthia T. Luk · 2022 · Molecular Metabolism
  10. Vasculature is getting Hip(po): Hippo signaling in vascular development and disease
    Sakurako Kobayashi, Andrew Graham Cox, Kieran F. Harvey, Benjamin M. Hogan · 2023 · Developmental Cell
  11. Central role of Yes-associated protein and WW-domain-containing transcriptional co-activator with PDZ-binding motif in pancreatic cancer development
    Enrique Rozengurt, Guido Eibl · 2019 · World Journal of Gastroenterology
  12. Metformin inhibits mTOR and c-Myc by decreasing YAP protein expression in OSCC cells
    Ying Wang, Yafei Zhang, Xiaomei Feng, Hui Tian, Xucheng Fu, Weiting Gu, Yong Wen · 2020 · Oncology Reports
  13. Inter-set stretch: A potential time-efficient strategy for enhancing skeletal muscle adaptations
    Schoenfeld, Brad J., Wackerhage, Henning, De Souza, Eduardo · 2022 · Frontiers in Sports and Active Living
  14. What are the potential mechanisms of fatigue-induced skeletal muscle hypertrophy with low-load resistance exercise training?
    Luke D. Flewwelling, Sarkis J. Hannaian, V. Cao, Thomas Chaillou, Tyler A. Churchward‐Venne, Arthur J. Cheng · 2024 · American Journal of Physiology-Cell Physiology
  15. Cellular feedback dynamics and multilevel regulation driven by the hippo pathway
    Jiwon Park, Carsten Gram Hansen · 2021 · Biochemical Society Transactions
  16. The aryl hydrocarbon receptor promotes differentiation during mouse preimplantational embryo development
    Ana Nacarino-Palma, Francisco Javier González-Rico, Claudia M. Rejano-Gordillo, Ana Ordiales-Talavero, Jaime M. Merino, Pedro M. Fernández‐Salguero · 2021 · Stem Cell Reports
  17. Deregulation and Therapeutic Potential of the Hippo Pathway in Cancer
    Kimberly C. Lin, Hyun Woo Park, Kun‐Liang Guan · 2017 · Annual Review of Cancer Biology
  18. FTY720-induced endocytosis of yeast and human amino acid transporters is preceded by reduction of their inherent activity and TORC1 inhibition
    Céline Barthelemy, Abdoulaye Oury Barry, Laure Twyffels, Bruno André · 2017 · Scientific Reports
  19. TOR Complex 1: Orchestrating Nutrient Signaling and Cell Cycle Progression
    Magdalena Foltman, Alberto Sánchez‐Díaz · 2023 · International Journal of Molecular Sciences
  20. AR activates YAP/TAZ differentially in prostate cancer
    Omar Salem, Siyang Jia, Bin‐Zhi Qian, Carsten Gram Hansen · 2023 · Life Science Alliance
  21. Bisphenol A induces placental ferroptosis and fetal growth restriction via the YAP/TAZ-ferritinophagy axis
    Yanan Sun, Menghan Sha, Qin Yu, Juan Xiao, Wei Li, Shufang Li, Suhua Chen · 2023 · Free Radical Biology and Medicine
  22. Discovery of YAP1/TAZ pathway inhibitors through phenotypic screening with potent anti-tumor activity via blockade of Rho-GTPase signaling
    Keith Graham, Philip Lienau, Benjamin Bader, Stefan Prechtl, Jan Naujoks, Ralf Lesche, Joerg Weiske, Julia Kuehnlenz, Krzysztof Brzezinka, Lisette Potze et al. · 2024 · Cell chemical biology
  23. Positive feedback between arginine methylation of YAP and methionine transporter SLC43A2 drives anticancer drug resistance
    Xia-Lu Hong, Chenkai Huang, Hui Qian, Chen‐Hong Ding, Fang Liu, Huan-Yu Hong, Shuqing Liu, Si‐Han Wu, Xin Zhang, Wei‐Fen Xie · 2025 · Nature Communications
  24. Control of amino acid transport into Chinese hamster ovary cells
    Darren Geoghegan, Claire L. Arnall, Diane Hatton, Joanne Noble‐Longster, Christopher A. Sellick, Tarik Senussi, David C. James · 2018 · Biotechnology and Bioengineering
  25. Prp19 Is an Independent Prognostic Marker and Promotes Neuroblastoma Metastasis by Regulating the Hippo-YAP Signaling Pathway
    Yuanxia Cai, Kai Chen, Cheng Cheng, Yonghu Xu, Qianqian Cheng, Guofeng Xu, Yeming Wu, Zhixiang Wu · 2020 · Frontiers in Oncology
  26. Targeting amino acid metabolism to inhibit gastric cancer progression and promote anti-tumor immunity: a review
    Yuchun Jiang, Tao Qing, Xuehan Qiao, Yufei Yang, Peng Chen, Miao Han, Kebin Dong, Wei Zhang, Min Xu, Deqiang Wang et al. · 2025 · Frontiers in Immunology
  27. Peripheral nerves modulate the peri-implant osteogenesis under type 2 diabetes through exosomes derived from schwann cells via miR-15b-5p/Txnip signaling axis
    Yingying Wang, Fang Qu, Yaqin Wu, Ke Lan, Yingyi Shen, Ziang Wu, Qi Zhong, Ximeng Cao, Zhen Fan, Chun Hui Xu · 2025 · Journal of Nanobiotechnology
  28. Hippo/YAP signaling’s multifaceted crosstalk in cancer
    Jie Zhang, Haipeng Wu, Xinxin Ren, Zhuoshi Chen, Siyu Ye, Shuchang Chen, Jie Fang, Qirou Wu, Tiejun Zhao · 2025 · Frontiers in Cell and Developmental Biology
  29. The LKB1–TSSK1B axis controls YAP phosphorylation to regulate the Hippo–YAP pathway
    Cho-Long Kim, Su-Bin Lim, Sue-Hee Choi, Dong Hyun Kim, Ye Eun Sim, Eun-Hye Jo, Keeeun Kim, Keesook Lee, Hee-Sae Park, Su Bin Lim et al. · 2024 · Cell Death and Disease
  30. Load-induced human skeletal muscle hypertrophy: Mechanisms, myths, and misconceptions
    Derrick W. Van Every, Matthew J. Lees, Brandan Wilson, Jeff Nippard, Stuart M. Phillips · 2025 · Journal of sport and health science/Journal of Sport and Health Science
  31. Emerging roles for angiomotin in the nervous system
    Michael Wigerius, Dylan P. Quinn, James P. Fawcett · 2020 · Science Signaling
  32. The mammalian target of rapamycin contributes to synovial fibroblast pathogenicity in rheumatoid arthritis
    Brianne E. Barker, Megan M. Hanlon, Viviana Marzaioli, Conor M. Smith, Clare C. Cunningham, Jean M. Fletcher, Douglas James Veale, Ursula Fearon, Mary Canavan · 2023 · Frontiers in Medicine
  33. Type I collagen reduces lipid accumulation during adipogenesis of preadipocytes 3T3-L1 via the YAP-mTOR-autophagy axis
    Yanfang Gao, Kai Ma, Yu Kang, Weiwei Liu, Xiaoling Liu, Xinyu Long, Toshihiko Hayashi, Shunji Hattori, Kazunori Mizuno, Hitomi Fujisaki et al. · 2022 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  34. Targeting YAP1 to improve the efficacy of immune checkpoint inhibitors in liver cancer: mechanism and strategy
    Yuting Gao, Yi Gong, Junlan Lu, Huiqin Hao, Xinli Shi · 2024 · Frontiers in Immunology
  35. Inhibition of YAP/TAZ pathway contributes to the cytotoxicity of silibinin in MCF-7 and MDA-MB-231 human breast cancer cells
    Jianing Fu, Weiwei Liu, Siyu Liu, Ruxiao Zhao, Toshihiko Hayashi, Haina Zhao, Yinlanqi Xiang, Kazunori Mizuno, Shunji Hattori, Hitomi Fujisaki et al. · 2024 · Cellular Signalling
  36. A covalent inhibitor of the YAP–TEAD transcriptional complex identified by high-throughput screening
    Kayla Nutsch, Lirui Song, Emily Chen, Mitchell V. Hull, Arnab K. Chatterjee, Jian Jeffery Chen, Michael J. Bollong · 2023 · RSC Chemical Biology
  37. Hippo pathway in intestinal diseases: focusing on ferroptosis
    Hongwei Deng, Qiuting Jia, Xin Ming, Yuxin Sun, Yuxuan Lu, Li Liu, Jun F. Zhou · 2023 · Frontiers in Cell and Developmental Biology
  38. The Hippo signaling pathway: from multiple signals to the hallmarks of cancers
    Ning Zhu, Ruizeng Yang, Xiaodong Wang, Liang Yuan, Xiaoyu Li, Fang Wei, Lei Zhang · 2023 · Acta Biochimica et Biophysica Sinica
  39. TGFβ1‐induced leucine limitation uncovered by differential ribosome codon reading
    Fabricio Loayza‐Puch, Koos Rooijers, Jelle Zijlstra, Behzad Moumbeini, Esther A. Zaal, Joachim A.F. Oude Vrielink, Rui Lopes, Alejandro Pineiro Ugalde, Celia R. Berkers, Reuven Agami · 2017 · EMBO Reports
  40. Chemical Approaches for Studying the Biology and Pharmacology of Membrane Transporters: The Histidine/Large Amino Acid Transporter SLC7A5 as a Benchmark
    Mariafrancesca Scalise, Raffaella Scanga, Lara Console, Michele Galluccio, Lorena Pochini, Cesare Indiveri · 2021 · Molecules
  41. β-elemene promotes the senescence of glioma cells through regulating YAP-CDK6 signaling.
    Danlu Yang, Xingxing Xu, Xin Wang, Wenjin Feng, Xiya Shen, Jingjing Zhang, Huitao Liu, Changnan Xie, Qian Wu, Xuemeng Miao et al. · 2021 · PubMed Central
  42. Protein expression of the amino acid transporter SLC7A5 in tumor tissue is prognostic in early-stage colorectal cancer
    Makiko Ogawa, Atsushi Tanaka, Masaki Maekawa, Kei Namba, Yusuke Otani, Jinru Shia, Julia Y. Wang, Michael H. A. Roehrl · 2024 · PLoS ONE
  43. The effects and post-exercise energy metabolism characteristics of different high-intensity interval training in obese adults
    Yang BaiQuan, Meng Cao, Zhu Congqing, Xiaodong Wang · 2025 · Scientific Reports
  44. Promoting Biological Similarity by Collagen Microfibers in 3D Colorectal Cancer-Stromal Tissue: Replicating Mechanical Properties and Cancer Stem Cell Markers.
    Naoko Sasaki, Yoshiya Asano, Yukiko Sorayama, Chihiro Kamimura, S. Kitano, Shinji Irie, Ryohei Katayama, Hiroshi Shimoda, M. Matsusaki · 2024 · Acta Biomaterialia
  45. YAP promotes global mRNA translation to fuel oncogenic growth despite starvation
    Daehee Hwang, Seonguk Baek, Jeeyoon Chang, Taejun Seol, Bomin Ku, Hongseok Ha, Hyeonji Lee, Suhyeon Cho, Tae‐Young Roh, Yoon Ki Kim et al. · 2024 · Experimental & Molecular Medicine
  46. Pipeline to evaluate YAP-TEAD inhibitors indicates TEAD inhibition represses NF2 -mutant mesothelioma
    Richard Cunningham, Siyang Jia, Krishna Pinganksha Purohit, Michaela Nosková, Marcin K Maniak, Yue Lin, Ning Sze Hui, Rebecca E. Graham, Adriano Giorgio Rossi, Justyna Cholewa-Waclaw et al. · 2025 · Life Science Alliance
  47. KLF15 transcriptionally activates LINC00689 to inhibit colorectal cancer development
    Yan Wei Cao, Jian Li, Gang Zhang, Hao Fang, Yongliang Du, Yan Liang · 2024 · Communications Biology
  48. Che-1/miR-590-3p/TAZ axis sustains multiple myeloma disease
    Tiziana Bruno, Valeria Catena, Giacomo Corleone, Clelia Cortile, Maria Chiara Cappelletto, Barbara Bellei, Francesca De Nicola, Bruno Amadio, Svitlana Gumenyuk, Francesco Marchesi et al. · 2024 · Leukemia
  49. Engineering stem cell metabolism using biomaterial-induced mechanotransduction
    Juul Verbakel, Jan de Boer · 2025 · Cell Biomaterials
  50. YAP/TAZ activation predicts clinical outcomes in mesothelioma and is conserved in in vitro model of driver mutations
    Richard Cunningham, Siyang Jia, Krishna Pinganksha Purohit, Omar Salem, Ning Sze Hui, Yue Lin, Neil O. Carragher, Carsten Gram Hansen · 2023 · Clinical and Translational Medicine
  51. JCAD deficiency delayed liver regenerative repair through the Hippo–YAP signalling pathway
    Li Zhang, Yong‐Yu Yang, Li Huitong Xie, Yuan Zhou, Zhenxing Zhong, Jia Ding, Zhong‐Hua Wang, Yu‐Li Wang, Xiuping Liu, Fa‐Xing Yu et al. · 2024 · Clinical and Translational Medicine
  52. Correlation of nuclear pIGF-1R/IGF-1R and YAP/TAZ in a tissue microarray with outcomes in osteosarcoma patients
    Eric R. Molina, Letitia K. Chim, Salah-Eddine Lamhamedi-Cherradi, Sana Mohiuddin, David C. McCall, Branko Cuglievan, Sandhya Krishnan, Robert W. Porter, Davis R. Ingram, Wei‐Lien Wang et al. · 2022 · Oncotarget
  53. Genes and Pathways Promoting Long‐Term Liver Repopulation by Ex Vivo hYAP‐ERT2 Transduced Hepatocytes and Treatment of Jaundice in Gunn Rats
    Esther A. Peterson, Zsuzsanna Polgár, Gnanapackiam Sheela Devakanmalai, Yanfeng Li, Fadi Luc Jaber, Wei Zhang, Xia Wang, Niloy Jafar Iqbal, John W. Murray, Namita Roy‐Chowdhury et al. · 2018 · Hepatology Communications
  54. Immunofluorescence Study of Endogenous YAP in Mammalian Cells
    Valentina Rausch, Carsten Gram Hansen · 2018 · Methods in molecular biology
  55. A feedback loop between Paxillin and Yorkie sustains Drosophila intestinal homeostasis and regeneration
    Dan Jiang, Pengyue Li, Yi Lu, Jiaxin Tao, Xue Hao, Xiaodong Wang, Wei Wu, Jinjin Xu, Haoen Zhang, Xiaoyu Li et al. · 2025 · Nature Communications
  56. Disulfidptosis mechanisms and therapeutic implications in cancer metabolic reprogramming and future perspectives
    Ronghui Chen, Jianhang You, Suxia Weng, Tao Zhao · 2025 · Discover Oncology
  57. Targeting emerging amino acid dependencies and transporters in cancer therapy
    Alfred Akinlalu, Emmanuel Ogberefor, Tommy Gao, Dali Sun · 2025 · Frontiers in Pharmacology
  58. PI3K regulates TAZ/YAP and mTORC1 axes that can be synergistically targeted
    Keith C. Garcia, Ali Khan, Krishnendu Ghosh, Sumit Sinha, Nicholas Scalora, Gillian DeWane, Colleen A. Fullenkamp, Nicole M. Merritt, Yuliia Drebot, Samuel Yu et al. · 2026 · JCI Insight
  59. Sirolimus for patients with progressive epithelioid hemangioendothelioma
    Alannah Smrke, Paul H. Huang, Robin L. Jones · 2020 · Cancer
  60. P4HA2-induced prolyl hydroxylation of YAP1 restricts vascular smooth muscle cell proliferation and neointima formation
    Liang Wang, Ting Liu, Yaofu Zheng, Jiamin Zhou, Hexiang Hua, Liming Kong, Weilin Huang, Xiaoping Peng, Tong Wen · 2023 · Life Sciences
  61. Essential Amino Acid Metabolism-Related Molecular Classification in Triple-Negative Breast Cancer
    Yajie Zhao, Chunrui Pu, Dechuang Jiao, Jiujun Zhu, Xuhui Guo, Zhenzhen Liu · 2021 · Epigenomics
  62. Translating molecular mechanisms of epithelioid hemangioendothelioma to improve patient outcome
    Alessia Beretta, Silvia Stacchiotti, Yuen Bun Tam, Robin L. Jones, Claudia Giani, Nadia Zaffaroni, Paul H. Huang, Sandro Pasquali · 2025 · Critical Reviews in Oncology/Hematology
  63. LAT1 supports mitotic progression through Golgi unlinking in an amino acid transport activity-independent manner
    Sakura Yanagida, Ryuzaburo Yuki, Youhei Saito, Yuji Nakayama · 2024 · Journal of Biological Chemistry
  64. Hyperaminoacidemia from interrupted glucagon signaling increases pancreatic acinar cell proliferation and size via mTORC1 and YAP pathways
    Chunhua Dai, Yue Zhang, Yulong Gong, Amber Thompson Bradley, Zihan Tang, Katelyn Sellick, Shristi Shrestha, Erick Spears, Brittney A. Covington, Jade E. Stanley et al. · 2024 · iScience
  65. Epithelioid Hemangioendothelioma: Treatment Landscape and Innovations for an Ultra-Rare Sarcoma
    Erica Maria Pimenta, Anirudh Goyal, Orly N. Farber, Elizabeth J. Lilley, Paul B. Shyn, Jiping Wang, Michael J. Wagner · 2025 · Current Treatment Options in Oncology
  66. Mitigation of Breast Cancer Cells’ Invasiveness via Down Regulation of ETV7, Hippo, and PI3K/mTOR Pathways by Vitamin D3 Gold-Nanoparticles
    Moumita Roy, Fazle Hussain · 2024 · International Journal of Molecular Sciences
  67. The molecular crosstalk of the hippo cascade in breast cancer: A potential central susceptibility
    Sulfath Thottungal Parambil, Gisha Rose Antony, Ajeesh Babu Littleflower, Lakshmi Subhadradevi · 2024 · Biochimie
  68. First-in-class SAM-competitive G9a inhibitor FLAV-27 as a disease-modifying therapy for Alzheimer disease
    Aina Bellver‐Sanchís, David Valle‐García, Carla Barbaraci, Fernando Romero-Becerra, Rohit Kumar Singh, Júlia Jarné‐Ferrer, Foteini Vasilopoulou, Alba Irisarri, Carmen Martínez-Fernández, Juan A. Fafián-Labora et al. · 2025 · Molecular Therapy
  69. ITCH inhibits alkaliptosis in human pancreatic cancer cells through YAP1-dependent SLC16A1 activation
    Xiutao Cai, Fangquan Chen, Hu Tang, Dandan Chao, Rui Kang, Daolin Tang, Jiao Liu · 2024 · The International Journal of Biochemistry & Cell Biology
  70. L-type amino acid transporter 1 promotes proliferation and invasion of human chorionic trophoblast and choriocarcinoma cells through mTORC1.
    Wenping Luo, Hongmei Zhang, Yan Zhang, Panpan Liang, Xiaojie Wang, Jing Ma, Dongmei Tan, Yi Tan, Jinlin Song, Ping Ji et al. · 2020 · PubMed Central
  71. Liver regeneration–associated hepatocellular YAP1 activation prevents colorectal cancer liver metastasis through glutamine competition
    Qiang Yu, Mincheng Yu, Peiyi Xie, Lei Guo, Yufei Zhao, Wenxin Xu, Xian Li, Mengyuan Wu, Zihao Zhang, Zheng Chen et al. · 2025 · Science Advances
  72. TXNIP mediates LAT1/SLC7A5 endocytosis to limit amino acid uptake in cells entering quiescence
    Jennifer Kahlhofer, Nikolas Marchet, Kristian Zubak, Brigitta Seifert, Madlen Hotze, Anna-Sophia Egger, Lucija Kucej, Claudia Manzl, Yannick Weyer, Sabine Weys et al. · 2025 · The EMBO Journal
  73. Neuromechanobiology: Bridging Mechanobiology and Neuroscience Through Evidence and Open Questions
    Karolina Zimkowska, Marc Riu-Villanueva, José Antonio del Rı́o · 2026 · Cells
  74. Hippo pathway at the crossroads of stemness and therapeutic resistance in breast cancer
    Giulia Schiavoni, Antonella Palmese, Stefano Scalera, Laura Cipriani, Davide Mascolo, Patrizia Vici, Teresa Arcuri, Lorena Filomeno, Eriseld Krasniqi, Giovanni Blandino et al. · 2026 · Molecular Oncology
  75. Wnt2bb signaling promotes pharyngeal chondrogenic precursor proliferation and chondrocyte maturation by activating Yap expression in zebrafish
    Xiaojuan Guo, Liping Yang, Yujie Wang, Mengna Yuan, Wenqing Zhang, Xinyu He, Qiang Wang · 2024 · Journal of genetics and genomics/Journal of Genetics and Genomics
  76. The Role of Collagen Matrix in the Development and Progression of Heterotopic Ossification in Tendon and Its Biological Mechanisms
    Chenxi Ren, Fa Liu, Shuyang Zhang, Huiyun Xu, Pengfei Yang · 2025 · The FASEB Journal
  77. TOR complex 1 negatively regulates NDR kinase Cbk1 to control cell separation in budding yeast
    Magdalena Foltman, Iván Mendez, Joan Josep Bech‐Serra, Carolina de la Torre, Jennifer L. Brace, Eric L. Weiss, María Lucas, Ethel Queralt, Alberto Sánchez‐Díaz · 2023 · PLoS Biology
  78. Abnormal activation of Yap/Taz contributes to the pathogenesis of tuberous sclerosis complex
    Bethany K Terry, Raehee Park, Seo‐Hee Cho, Peter B. Crino, Seonhee Kim · 2021 · Human Molecular Genetics
  79. TXNIP mediates LAT1/SLC7A5 endocytosis to reduce amino acid uptake in cells entering quiescence
    Jennifer Kahlhofer, Nikolas Marchet, Brigitta Seifert, Kristian Zubak, Madlen Hotze, Anna-Sophia Egger, Claudia Manzl, Yannick Weyer, Sabine Weys, Martin Offterdinger et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  80. Tension to Translation: External to Internal Processes in Muscle Hypertrophy
    Dominique Greyvenstein, James P. Newbold, Stuart M. Phillips · 2025 · Physiology
  81. L-type Amino Acid Transporter 1 as a Therapeutic Target in Pancreatic Cancer
    Ragnar Norrsell, Monika Posaric Bauden, Roland E. Andersson, Daniel Ansari · 2024 · Cancer Control
  82. Tissue stiffness heterogeneity in the jaw and temporomandibular joint: its impact on tumor metabolism and considerations for in vitro model development
    Lingjie Li, Ping Deng, Siyu Hou, Guangyue Li, Min Suo, Ling Xu, Chao Wang, Jinlin Song · 2025 · Frontiers in Physiology
  83. In vivo screen reveals specific roles of Hippo pathway components in development and regeneration
    Susanna E. Riley, Michaela Nosková, Shijia Xia, Richard Cunningham, Justyna Cholewa-Waclaw, Yi Feng, Carsten Gram Hansen · 2025 · Life Science Alliance
  84. Hippo signalling in cellular and tissue-level metabolism across health and disease
    Sophia Bigot, Aida Bahrami, Amin Dakhili Ardestani · 2026 · Trends in Endocrinology and Metabolism
  85. The functional relationship of Yap/Taz with autophagy functions in sarcopenia associated with aging
    Ardo Sanjaya, Ronny Lesmana, Hanna Goenawan, Iwan Setiawan, Nova Sylviana, Yuni Susanti Pratiwi, Fitriya N. Dewi, Unang Supratman · 2023 · Nutrition and Healthy Aging
  86. In vitro activation of ovarian follicles
    Kazuhiro Kawamura · 2023 · Elsevier eBooks
  87. Alpha-fetoprotein upregulates hepatocellular carcinoma cell-intrinsic PD-1 expression through the LATS2/YAP/TEAD1 pathway
    Guangxian Leng, Hongxia Gong, Guiyuan Liu, Yin Kong, Liuqing Guo, Youcheng Zhang · 2024 · Biochimica et Biophysica Acta (BBA) - General Subjects
  88. Enlarging Scalp Lesion in Pediatric Patient
    Ireland Wayt, Justin Lee, Patrick Tomboc, Zachary A. Zinn · 2025 · Pediatric Dermatology
  89. Special Issue on “Disease and the Hippo Pathway”
    Carsten Gram Hansen · 2019 · Cells
  90. Development of CRISPR/Cas-mediated gene editing in the retina
    FengJiu Li · 2020 · UTAS Research Repository
  91. The clinicopathological and prognostic values of TAZ and YAP expression in gastric cancer
    Shuai Shi, Ying Han, RUI YU ZHANG, GANG ZHI ZHANG · 2020
  92. Effect of CLN3-loss-of-function on cellular metabolism and signalling
    Katarzyna Więciorek-Płuciennik · 2022
  93. The effect of genetics and biochemistry on the pathogenesis of cholangiocarcinoma
    Mete Tuğcan Üçdal, Ayşe Buruş, Başak Çeltikçi · 2024 · International Journal of Hepatobiliary and Pancreatic Diseases
  94. First-in-Class SAM-Competitive G9a Inhibitor FLAV-27 as a Disease-Modifying Therapy for Alzheimer’s Disease
    Christian Griñán‐Ferré, Aina Bellver‐Sanchís, David Valle‐García, Carla Barbaraci, Fernando Romero-Beccera, rohit Singh, Foteini Vasilopoulou, Alba Irisarri, Carmen Martı́nez, Juan Fafián‐Labora et al. · 2025 · Research Square
  95. Spindle localization of YAP/TAZ maintains even distribution of YAP/TAZ in daughter cells
    Yuxing Huang · 2025 · Journal of Biosciences
  96. Network-based analysis reveals microRNA regulation of oncogenic pathways in SOX10-depleted uveal melanoma
    Chunyan Luan, Anja Wessely, Zhesi Zhang, Liang Zhang, Adrian Weich, Christopher Lischer, Carola Berking, Markus Vincent Heppt, Julio Vera, Xin Lai · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  97. Additional file 1 of A specific tRNA half, 5’tiRNA-His-GTG, responds to hypoxia via the HIF1α/ANG axis and promotes colorectal cancer progression by regulating LATS2
    Tao, En-Wei, Wang, Hao-Lian, Wing Yin Cheng, Liu, Qian-Qian, Chen, Ying-Xuan, Gao, Qin-Yan · 2021 · Figshare
  98. The Role of the Hippo Signaling Pathway in 7,12‐Dimethylbenz(a)anthracene (DMBA)‐Induced Follicular Depletion
    Serra Nur Ersoy, Aylin Yaba · 2026 · Molecular Reproduction and Development
  99. Brain cancer: Hippo signaling dysregulation, potential proteomic techniques, therapeutic strategies, and future perspectives
    Mehrose Ayoub Bhat, Insha Mushtaq, Weekar Younus Raja · 2026 · Elsevier eBooks
  100. Transcriptional control of PPP2CB by YAP1 and TEAD1 mediates AMPK inhibition and mTORC1 activation in vascular smooth muscle cells
    Sanjana Kumariya, Joanna Stuck, Arturo Grano de Oro, Islam Osman · 2026 · iScience